Company news
EVE Health Group Limited news in 2025
EVE Health Group Limited's news releases, calls and decks from 2025, newest first.
EVE Signs Telehealth Services Agreement with hubMed -Revised
November 19, 2025
EVE Signs Telehealth Services Agreement with hubMed
November 18, 2025
Medical Science Liaison Appointed
November 2, 2025
EVE Raises $1.1m to Accelerate Launches of Dyspro and Libbo
October 8, 2025
Dyspro Prescribed to First Patients
September 30, 2025
Eve Commences Distribution of Dyspro
September 21, 2025
Appointment of Dr Fiona Cousins to Scientific Advisory Board
September 14, 2025
Appendix 4E
August 29, 2025
Aust Regulatory Path Cleared for ED & Dysmenorrhea Products
July 20, 2025
EVE Submits First Commercial Purchase Order for Dyspro
July 6, 2025
Prescribing Agreement for ED and Dysmenorrhea Products
June 15, 2025
EVE Completes Nextract Acquisition
June 12, 2025
Results of Meeting
May 29, 2025
Notice of General Meeting/Proxy Form
April 29, 2025
Reinstatement to Quotation
April 14, 2025
EVE to Acquire Nextract, Expanding into $5.3B ED Market
April 14, 2025
Suspension from Quotation
April 4, 2025
Decks in 2025
- Investor Presentation (November 2025)
Investor deck · 14 slides · Nov 20, 2025
- Spark Plus Australian Equities Day 2025
Conference · 13 slides · Oct 3, 2025
- Shareholder Meeting (May 2025)
Shareholder meeting · 12 slides · May 29, 2025
- Merger or Acquisition (April 2025)
Merger or acquisition · 14 slides · Apr 14, 2025